Literature DB >> 14985541

Fusion of the antiferritin antibody VL domain to barnase results in enhanced solubility and altered pH stability.

Sergey P Martsev1, Yaroslav I Tsybovsky, Oleg A Stremovskiy, Sergey G Odintsov, Taras G Balandin, Paolo Arosio, Zinaida I Kravchuk, Sergey M Deyev.   

Abstract

Chimeric immunotoxins that combine antigen recognition domains of antibodies and cytotoxic RNases have attracted much attention in recent years as potential targeted agents for cancer immunotherapy. In an attempt to obtain a structurally minimized immunofusion for folding/stability studies, we constructed the chimeric protein VL-barnase. The chimera comprises a small cytotoxic enzyme barnase, ribonuclease from Bacillus amyloliquefaciens, fused to the C-terminus of the light chain variable domain (VL) of the anti-human ferritin monoclonal antibody F11. While the individual VL domain was expressed in Escherichia coli as insoluble protein packed into inclusion bodies, its fusion to barnase resulted in a significant ( approximately 70%) fraction of soluble protein, with only a minor insoluble fraction ( approximately 30%) packed into inclusion bodies. The in vivo solubilizing effect of barnase was also observed in vitro and suggests a chaperone-like role that barnase exerted with regard to the N-terminal VL domain. Cytoplasmic VL-barnase was analyzed for structural and functional properties. The dimeric state of the chimeric protein was demonstrated by size-exclusion chromatography, thus indicating that fusion to barnase did not abrogate the intrinsic dimerization propensity of the VL domain. Ferritin-binding affinity and specificity in terms of constants of association with isoferritins were identical for the isolated VL domain and its barnase fusion, and RNase activity remained unchanged after the fusion. Intrinsic fluorescence spectra showed a fully compact tertiary structure of the fusion protein. However, significantly altered pH stability of the fusion protein versus individual VL and barnase was shown by the pH-induced changes in both intrinsic fluorescence and binding of ANS. Together, the results indicate that VL-barnase retained the antigen-binding affinity, specificity and RNase activity pertinent to the two individual constituents, and that their fusion into a single-chain chimeric protein resulted in an altered tertiary fold and pH stability.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985541     DOI: 10.1093/protein/gzh011

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  8 in total

1.  Production of recombinant antitumor antibodies by HEK-293 cells.

Authors:  S M Deyev; O A Stremovskiy; S V Lukash; D V Karpenko; O L Polyanovsky; R V Petrov
Journal:  Dokl Biochem Biophys       Date:  2006 Jan-Feb       Impact factor: 0.788

Review 2.  Biotechnological applications of recombinant single-domain antibody fragments.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2011-06-09       Impact factor: 5.328

3.  Modern Technologies for Creating Synthetic Antibodies for Clinical application.

Authors:  S M Deyev; E N Lebedenko
Journal:  Acta Naturae       Date:  2009-04       Impact factor: 1.845

4.  Quantum dots for molecular diagnostics of tumors.

Authors:  T A Zdobnova; E N Lebedenko; S М Deyev
Journal:  Acta Naturae       Date:  2011-01       Impact factor: 1.845

5.  Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli.

Authors:  Hans Peter Sørensen; Kim Kusk Mortensen
Journal:  Microb Cell Fact       Date:  2005-01-04       Impact factor: 5.328

6.  Specific visualization of tumor cells using upconversion nanophosphors.

Authors:  E A Grebenik; A N Generalova; A V Nechaev; E V Khaydukov; K E Mironova; O A Stremovskiy; E N Lebedenko; A V Zvyagin; S M Deyev
Journal:  Acta Naturae       Date:  2014-10       Impact factor: 1.845

Review 7.  Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology.

Authors:  Olga Shilova; Polina Kotelnikova; Galina Proshkina; Elena Shramova; Sergey Deyev
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

8.  Self-assembling complexes of quantum dots and scFv antibodies for cancer cell targeting and imaging.

Authors:  Tatiana A Zdobnova; Oleg A Stremovskiy; Ekaterina N Lebedenko; Sergey M Deyev
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.